Healthcare / Pharmaceutical RetailersUpdated 2026-05-10 22:07 UTC

PRA/PINK stock hub

PRA/PINK has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

PRA/PINKis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

368.1M

Prague Stock Exchange

Market data

Price

Recent price action with selectable time range.

PRA/PINKPRA/PINK

—

Loading chart…

In the news

Latest news · PRA/PINK

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-231.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All PRA/PINK market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

145

Groups with data

Currency

CZK

Showing 145 of 145 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Czech Republic
Country code	CZ
Employees	0
Enterprise value	CZK 403.6M
Exchange	Prague Stock Exchange
Financial currency	CZK
First seen	2026-05-10
Industry	Pharmaceutical Retailers
Isin	CZ0009009874
Last refreshed	2026-05-10
Market cap	CZK 368.1M
Price	CZK 136
Price currency	CZK
Sector	Healthcare
Sic	5912
Symbol	pra/PINK
Website	https://www.pilulka.cz

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-34.16%
EV Earnings	-3.21x
EV/FCF	-6.2x
EV/Sales	0.31x
FCF yield	-17.67%
P/B ratio	-3.8x
P/S ratio	0.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-8.43%
EBITDA Margin	-6.92%
Gross margin	14.07%
Gross Profit	CZK 183.5M
Net Income	CZK -125.7M
Pretax Margin	-9.69%
Profit Margin	-9.64%
ROA	-20.29
ROCE	122.7
ROIC	-231.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-33.02%
Cagr3y	-34.31%
Cagr5y	-37.27%
Revenue Growth	-38.82x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CZK 3.85
Assets	CZK 237.3M
Cash	CZK 10.2M
Current Assets	CZK 146.2M
Current Liabilities	CZK 327M
Debt	CZK 48.4M
Debt FCF	CZK -0.74
Equity	CZK -96.7M
Interest Coverage	-8.91
Liabilities	CZK 334.1M
Long Term Assets	CZK 91.2M
Long Term Liabilities	CZK 7.1M
Net Cash	CZK -38.3M
Net Cash By Market Cap	CZK -10.4
Tangible Book Value	CZK -152M
Tangible Book Value Per Share	CZK -56.16
WACC	10.91

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.45
Inventory Turnover	14.85
Net Working Capital	CZK -144.9M
Quick ratio	0.27
Working Capital	CZK -180.8M

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-33%
200-day SMA	163.6
3Y total return	-71.67%
50-day SMA	122.4
50-day SMA vs 200-day SMA	50under200
5Y total return	-90.29%
All Time High	1,800
All Time High Change	-92.44%
All Time High Date	2022-01-10
All Time Low	80
All Time Low Change	70%
All Time Low Date	2025-01-10
ATR	7.47
Beta	0.99
Beta1y	0.65
Beta2y	0.74
Ch YTD	-20
High	136
High52	215
High52 Date	2025-05-13
High52ch	-36.74%
Low	130
Low52	99
Low52 Date	2026-04-07
Low52ch	37.37%
Ma50ch	11.16%
Price vs 200-day SMA	-16.88%
RSI	57.02
RSI Monthly	37.34
RSI Weekly	44.25
Sharpe ratio	-0.83x
Sortino ratio	-1.09
Tr YTD	-20
Tr1m	36%
Tr1w	0.74%
Tr3m	-6.21%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CZK -109.9M
Operating margin	-8.43

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	64,151,000
Shares Out	2,706,678

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CZK -65.1M
Average Volume	1,866.25x
Bv Per Share	-34.72
CAPEX	CZK -20.1M
Ch1m	36
Ch1w	0.74
Ch1y	-33
Ch3m	-6.21
Ch3y	-71.67
Ch5y	-90.29
Ch6m	-25.27
Change	6.25%
Change From Open	4.62
Close	128
Days Gap	1.56
Depreciation Amortization	19,649,000
Dollar Volume	10,744
Earnings Date	2026-04-02
EBIT	CZK -109.9M
EBITDA	CZK -90.3M
EPS	CZK -46.46
F Score	1
FCF	CZK -65.1M
FCF EV Yield	-16.12x
FCF Per Share	CZK -24.03
Financing CF	64,151,000
Fiscal Year End	December
Founded	2,013
Goodwill	19,023,000
Investing CF	-11,502,000
Is Primary Listing	1
Ma150	155
Ma150ch	-12.25%
Ma20	126.6
Ma20ch	7.45%
Net CF	6,578,000
Open	130
Position In Range	100
Ppne	21,137,000
Price Date	2026-05-07
Relative Volume	0.04x
Revenue	1,304,243,000x
Tr6m	-25.27%
Volume	79
Z Score	0.68

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does PRA/PINK pay a dividend?

Capital-return profile for this ticker.

Performance

PRA/PINK stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Technical

PRA/PINK momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.0

Neutral momentum band

Price vs 200-day MA

-16.9%

50/200-day relationship not available

Beta (5Y)

0.99

Moves roughly with the market

Sharpe ratio

-0.83

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About PRA/PINK

Hub-level FAQ points readers to the deeper analysis pages.

What is the current pra/PINK stock rating?

pra/PINK is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full pra/PINK analysis?

The full report lives at /stocks/pra/PINK/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for pra/PINK?

The latest report frames pra/PINK around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the pra/PINK page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.